FSLR
63
5
ADP
59
-2
FCX
50
-2
SPG
53
2
WFC
58
-2
PEG
55
2
PGR
59
5
CA
25
-7
FRT
46
3
CHD
34
2
AAP
29
-3
DG
14
-3
NUE
39
-4
EL
34
-3
CCI
23
-2
CRM
72
-3
PHM
53
-4
DNB
58
2
FDX
34
-2
XRAY
47
-2
FSLR
63
5
ADP
59
-2
FCX
50
-2
SPG
53
2
WFC
58
-2
PEG
55
2
PGR
59
5
CA
25
-7
FRT
46
3
CHD
34
2
AAP
29
-3
DG
14
-3
NUE
39
-4
EL
34
-3
CCI
23
-2
CRM
72
-3
PHM
53
-4
DNB
58
2
FDX
34
-2
XRAY
47
-2
Financhill
Back

Silence Therapeutics PLC Quote, Financials, Valuation and Earnings

The dark truth about AI

Click here to learn more...
Sell
36

SLN
Silence Therapeutics PLC

Last Price:
6.50
Seasonality Move:
5.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Silence Therapeutics PLC Price Quote

$6.50
+0.05 (+-1.52%)
(Updated: December 14, 2024 at 5:52 AM ET)

Silence Therapeutics PLC Key Stats

Sell
36
Silence Therapeutics PLC (SLN) is a Sell
Day range:
$6.36 - $6.86
52-week range:
$5.81 - $27.72
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.16
P/B ratio:
2.46%
Volume:
280.9K
Avg. volume:
733.3K
1-year change:
-57%
Market cap:
$311.6M
Revenue:
$31.6M
EPS:
$-1.68

How Much Does Silence Therapeutics PLC Make?

Is Silence Therapeutics PLC Growing As A Company?

Silence Therapeutics PLC Stock Price Performance

What Is Silence Therapeutics PLC 52-Week High & Low?

Silence Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Silence Therapeutics PLC?

Is Silence Therapeutics PLC Cash Flow Positive?

  • What Is SLN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$55.8M
  • What Is Silence Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $158.2M
  • What Is Silence Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$87.5M

Silence Therapeutics PLC Return On Invested Capital

  • Is Management Doing A Good Job?
    SLN return on invested capital is -79.63%
  • What Is Silence Therapeutics PLC Return On Assets?
    ROA measures how assets are converting to revenues and is -39.52%
  • What Is SLN Return On Equity?
    ROE is a measure of profitability and is -79.63%

Silence Therapeutics PLC Earnings Date & Stock Price

Silence Therapeutics PLC Competitors

Silence Therapeutics PLC Dividend Yield

Silence Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -477.56%
Revenue: -58.06% -62.91%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 53.70
Upside from Last Price: 732.51%

Major Shareholders

  • How many SLN shares are owned by institutional investors?
    25.1M SLN shares are owned by institutional investors
  • How many SLN shares are owned by insiders?
    63.3M SLN shares are owned by insiders